Financial Data and Key Metrics Changes - Operating earnings per share were reported at $0.85, reflecting a 29% increase year-over-year, and a 3% increase when excluding significant items [6][26] - Book value for diluted share, excluding AOCI, increased by 15% [9] - The annualized effective tax rate rose by 80 basis points to 23.5% compared to the previous year [27] Business Line Data and Key Metrics Changes - In the Consumer Division, Life and Health sales decreased by 9% year-over-year, while direct-to-consumer life sales increased by 9% [10][11] - Annuity collected premiums rose by 26% compared to the prior year, with the average policy size increasing by 6% [15] - Worksite insurance sales grew by 33%, driven by a mix of reservice business and new client acquisition [19] Market Data and Key Metrics Changes - Client assets in brokerage and advisory decreased by 3% year-over-year to $2.6 billion, although new accounts increased by 10% [16] - The producing agent count decreased by 9% year-over-year, but there was a 2% growth in recruiting sequentially [17][22] Company Strategy and Development Direction - The company introduced a new Medicare Supplement product and launched the Optavise brand to unify its worksite offerings [8][18] - The focus remains on enhancing agent productivity and expanding the product portfolio, particularly in the Medicare segment [12][20] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about increasing sales momentum in the second half of the year, despite ongoing challenges from COVID impacts and market volatility [34][35] - The company is well-positioned to respond to changing macroeconomic conditions, with a strong capital position and a focus on organic and inorganic investments [8][24] Other Important Information - The company returned $77 million to shareholders in the second quarter, including $60 million in share buybacks, resulting in a 12% reduction in weighted average diluted shares outstanding [8][28] - The consolidated RBC ratio was reported at 360%, with a target of 375% [33] Q&A Session Summary Question: Share repurchase pace and RBC ratio timeframe - Management indicated that share repurchases would be dialed back in the near term as they aim to build back to the target RBC and holdco liquidity levels [39] Question: Non-variable investment income levels - Management noted that the increase in non-variable investment income was due to favorable market conditions, but it may not be a permanent trend [42][45] Question: RBC ratio recovery expectations - Management explained that the RBC ratio would likely recover symmetrically if equity markets improve, but the recovery would be gradual [48][49] Question: Advertising spend trends - Management clarified that advertising spend is managed based on internal metrics and the effectiveness of ad placements, leading to fluctuations in spending [50][52] Question: Impact of NAIC RBC charges on CLO investments - Management stated that any changes would be manageable and they are monitoring the situation closely [54] Question: Outlook for annuity gross deposits - Management highlighted that demand for annuities tends to increase during market volatility, contributing to strong growth in annuity sales [56][60] Question: Equity market sensitivity in annuities - Management confirmed that the GAAP impacts are symmetrical, with favorable outcomes expected if market conditions reverse [62][64]

| --- | --- | |------------------------------------------------------------------------------------------|-------| | | | | | | | | | | Second Quarter 2022 Financial and operating results for the period ended June 30, 2022 | | | August 1, 2022 | | | Unless otherwise specified, comparisons in this presentation are between 2Q21 and 2Q22. | | CNO Financial Group 1 Important Legal Information Forward-Looking Statements Certain statements made in this presentation should be considered forward-looking statements a ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission File Number 001-31792 CNO Financial Group, Inc. Delaware 75-3108137 | --- | --- | --- | |------------------------------------------- ...

Financial Performance - Net operating income decreased from $752 million in 1Q21 to $511 million in 1Q22[15] - Total insurance product margin decreased by $20 million, a 10% decrease [17] - Annuity margin decreased by $13 million, a 23% decrease [17] - Life margin decreased by $7 million, a 27% decrease [17] Sales and Premiums - Total Life sales increased by 3%, with Direct-to-Consumer (D2C) Life sales up by 16%[10] - Annuity collected premiums increased by 13%[10] - Supplemental Health New Annualized Premium (NAP) increased by 8%, and Long-Term Care increased by 6%[10] - Life and Health insurance sales in the Worksite Division increased by 8%[12] Assets and Capital - Client assets in Brokerage and Advisory increased by 16% year-over-year, reaching $28351 billion[9, 39] - Share repurchases amounted to $100 million in 1Q22[14] - Dividends paid totaled $16 million in 1Q22[14] - The company targets a consolidated Risk-Based Capital (RBC) ratio of approximately 375%[27]

Call Start: 11:00 January 1, 0000 11:44 AM ET CNO Financial Group, Inc. (NYSE:CNO) Q1 2022 Earnings Conference Call May 3, 2022, 11:00 AM ET Company Participants Gary Bhojwani – Chief Executive Officer Eric R. Johnson – President at 40/86 Advisors, Inc. and Chief Investment Officer Paul McDonough – Chief Financial Officer Jennifer Childe – Vice President of Investor Relations and Sustainability Conference Call Participants Ryan Krueger – Keefe, Bruyette & Woods Erik Bass – Autonomous Research Daniel Bergman ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ______ to ______ Commission File Number 001-31792 CNO Financial Group, Inc. | --- | --- | --- | |-------------------------------------------------------------- ...

CNO Financial Group, Inc. (NYSE:CNO) Q4 2021 Earnings Conference Call February 9, 2022 11:00 AM ET Company Participants Jennifer Childe - VP, IR and Sustainability Gary Bhojwani - CEO & CNO Paul McDonough - CFO Conference Call Participants Erik Bass - Autonomous Research John Barnidge - Piper Sandler Humphrey Lee - Dowling and Partners Cullen Johnson - B. Riley Securities Ryan Krueger - KBW Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Times ...

Fourth Quarter 2021 Financial and operating results for the period ended December 31, 2021 February 8, 2022 Unless otherwise specified, comparisons in this presentation are between 4Q20 and 4Q21. Important Legal Information Forward-Looking Statements Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission File Number 001-31792 CNO Financial Group, Inc. Delaware 75-3108137 | --- | --- | --- | |--------------------------------------- ...

Third Quarter 2021 Financial and operating results for the period ended September 30, 2021 October 27, 2021 Unless otherwise specified, comparisons in this presentation are between 3Q20 and 3Q21. Important Legal Information Forward-Looking Statements Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors ...